Anton Kolomeyer is an Ophthalmology physician affiliated with Rider University. OpenAlex indexes 118 publications with 1,002 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
251 S Lincoln Ave
Vineland, NJ 083617802
Telephone
856-691-8188Provider last certified this registry record 23 Feb 2026.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year202537 payments$62,159openpaymentsdata.cms.gov ↗
- Regeneron Healthcare Solutions, Inc.Program year202546 payments$41,787openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
96.5%Antineovascularisation agents74.8%Faricimab-svoa100%Part B, office-administered≥55 patientsComplement Inhibitor17.2%Avacincaptad pegol100%Part B, office-administered≥23 patients+ 7 more classes in this area
Cancer & immunology
2.7%Vascular Endothelial Growth Factor Inhibitor2.7%Aflibercept100%Part B, office-administered≥81 patientsMusculoskeletal
0.4%Cyclooxygenase Inhibitor0.4%Ketorolac Tromethamine100%Part D≥22 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- EFFICACY OF MARIBAVIR IN VALGANCICLOVIR-RESISTANT CYTOMEGALOVIRUS RETINITIS
Retinal Cases & Brief Reports
2023 - The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus
Ophthalmic surgery, lasers & imaging retina
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”